Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two - No Study Results Posted

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two (CARE-MS II)

This study is ongoing, but not recruiting participants.

Study NCT00548405 Information provided by Genzyme

First Received: October 22, 2007 Last Updated: October 28, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2012
Estimated Primary Completion Date:	April 2012 (Final data collection date for primary outcome measure)